Could a diabetes pill help teens with fatty liver?
Disease control
Not yet recruiting
This study tests whether a type 2 diabetes drug (SGLT2 inhibitor) can safely reduce liver fat in adolescents aged 12-20 who have obesity and non-alcoholic fatty liver disease (NAFLD). About 40 participants will receive either the drug or a placebo for several months. The main goa…
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated May 26, 2026 09:53 UTC